Details on upcoming events are not yet available.
Extraordinary General Meeting of Shareholders
Location: the offices of the Company's counsel (Zysman, Aharoni, Gayer & Co.) at "Beit Zion", 41-45 Rothschild Blvd., 8th Fl., Tel Aviv 6578401, Israel
Alcobra Fourth Quarter 2013 Results
Biotechnology Industry Organization 2014 BIO CEO & Investor Conference
Location: The Waldorf Astoria, NYC
Bloomberg TV New ADHD Drug from Trial to Market
25th Annual Piper Jaffray Healthcare Conference
Location: New York Palace Hotel, New York City
Alcobra Third Quarter Results
AACAP 60th Annual Meeting
FRAXA Investigators Meeting
Aegis Capital 2013 Annual Healthcare Conference
Stifel Nicolaus 2013 Annual Healthcare Conference
Speaker: Yaron Daniely, President and CEO
Alcobra Ltd. Annual General Meeting of the Shareholders
Proxy Materials Page:
Location: 41-45 Rothschild Blvd., 8th Fl., Tel Aviv 65784, Israel
Senior management along with Dr. Lenard A. Adler will provide an update on ADHD diagnosis according to the newly published DSM-V, current therapies, and advancements being made in diagnosis and treatment.
Analysts and investors who would like to register or learn more about the event should contact Diane Imas or Alex Woodbury of KCSA Strategic Communications at (212) 896-1267 or firstname.lastname@example.org. Registration is required as space is limited.
Location: New York City
Alcobra Second Quarter 2013 Results
IATI-Biomed Israel 2013 Conference
NASDAQ Opening Bell Ceremony